Global Heart Failure Drugs Market Growth 2020-2025
According to this study, over the next five years the Heart Failure Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Heart Failure Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Heart Failure Drugs, covering the supply chain analysis, impact assessment to the Heart Failure Drugs market size growth rate in several scenarios, and the measures to be undertaken by Heart Failure Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
The proportion of ARNIs in 2018 is about 19%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Reduced Ejection Fraction
Preserved Ejection Fraction
The most proportion of heart failure drugs is reduced ejection fraction and the sales proportion is 69%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Sun Pharma
Pfizer
Hikma
Teva
AstraZeneca
Amgen
Cipla
Roche
Merck & Co.
Mylan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Heart Failure Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Heart Failure Drugs market by identifying its various subsegments.
Focuses on the key global Heart Failure Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Heart Failure Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Heart Failure Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Failure Drugs Consumption 2015-2025
2.1.2 Heart Failure Drugs Consumption CAGR by Region
2.2 Heart Failure Drugs Segment by Type
2.2.1 ACEI
2.2.2 Angiotensin II Receptor Blockers
2.2.3 ARNIs
2.2.4 Beta Blockers
2.2.5 Aldosterone Antagonists
2.2.6 Diuretics
2.3 Heart Failure Drugs Consumption by Type
2.3.1 Global Heart Failure Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Heart Failure Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Heart Failure Drugs Sale Price by Type (2015-2020)
2.4 Heart Failure Drugs Segment by Application
2.4.1 Reduced Ejection Fraction
2.4.2 Preserved Ejection Fraction
2.5 Heart Failure Drugs Consumption by Application
2.5.1 Global Heart Failure Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Heart Failure Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Heart Failure Drugs Sale Price by Type (2015-2020)
3 Global Heart Failure Drugs by Company
3.1 Global Heart Failure Drugs Sales Market Share by Company
3.1.1 Global Heart Failure Drugs Sales by Company (2018-2020)
3.1.2 Global Heart Failure Drugs Sales Market Share by Company (2018-2020)
3.2 Global Heart Failure Drugs Revenue Market Share by Company
3.2.1 Global Heart Failure Drugs Revenue by Company (2018-2020)
3.2.2 Global Heart Failure Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Heart Failure Drugs Sale Price by Company
3.4 Global Heart Failure Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Heart Failure Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Heart Failure Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Heart Failure Drugs by Regions
4.1 Heart Failure Drugs by Regions
4.2 Americas Heart Failure Drugs Consumption Growth
4.3 APAC Heart Failure Drugs Consumption Growth
4.4 Europe Heart Failure Drugs Consumption Growth
4.5 Middle East & Africa Heart Failure Drugs Consumption Growth
5 Americas
5.1 Americas Heart Failure Drugs Consumption by Countries
5.1.1 Americas Heart Failure Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Heart Failure Drugs Value by Countries (2015-2020)
5.2 Americas Heart Failure Drugs Consumption by Type
5.3 Americas Heart Failure Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Heart Failure Drugs Consumption by Regions
6.1.1 APAC Heart Failure Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Heart Failure Drugs Value by Regions (2015-2020)
6.2 APAC Heart Failure Drugs Consumption by Type
6.3 APAC Heart Failure Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Heart Failure Drugs by Countries
7.1.1 Europe Heart Failure Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Heart Failure Drugs Value by Countries (2015-2020)
7.2 Europe Heart Failure Drugs Consumption by Type
7.3 Europe Heart Failure Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Heart Failure Drugs by Countries
8.1.1 Middle East & Africa Heart Failure Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Heart Failure Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Heart Failure Drugs Consumption by Type
8.3 Middle East & Africa Heart Failure Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Heart Failure Drugs Distributors
10.3 Heart Failure Drugs Customer
11 Global Heart Failure Drugs Market Forecast
11.1 Global Heart Failure Drugs Consumption Forecast (2021-2025)
11.2 Global Heart Failure Drugs Forecast by Regions
11.2.1 Global Heart Failure Drugs Forecast by Regions (2021-2025)
11.2.2 Global Heart Failure Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Heart Failure Drugs Forecast by Type
11.8 Global Heart Failure Drugs Forecast by Application
12 Key Players Analysis
12.1 Novartis
12.1.1 Company Information
12.1.2 Heart Failure Drugs Product Offered
12.1.3 Novartis Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Sun Pharma
12.2.1 Company Information
12.2.2 Heart Failure Drugs Product Offered
12.2.3 Sun Pharma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sun Pharma Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Heart Failure Drugs Product Offered
12.3.3 Pfizer Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Hikma
12.4.1 Company Information
12.4.2 Heart Failure Drugs Product Offered
12.4.3 Hikma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hikma Latest Developments
12.5 Teva
12.5.1 Company Information
12.5.2 Heart Failure Drugs Product Offered
12.5.3 Teva Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Teva Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Heart Failure Drugs Product Offered
12.6.3 AstraZeneca Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Amgen
12.7.1 Company Information
12.7.2 Heart Failure Drugs Product Offered
12.7.3 Amgen Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Amgen Latest Developments
12.8 Cipla
12.8.1 Company Information
12.8.2 Heart Failure Drugs Product Offered
12.8.3 Cipla Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Cipla Latest Developments
12.9 Roche
12.9.1 Company Information
12.9.2 Heart Failure Drugs Product Offered
12.9.3 Roche Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Roche Latest Developments
12.10 Merck & Co.
12.10.1 Company Information
12.10.2 Heart Failure Drugs Product Offered
12.10.3 Merck & Co. Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Merck & Co. Latest Developments
12.11 Mylan
12.11.1 Company Information
12.11.2 Heart Failure Drugs Product Offered
12.11.3 Mylan Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Mylan Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Heart Failure Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of ACEI
Table 5. Major Players of Angiotensin II Receptor Blockers
Table 6. Major Players of ARNIs
Table 7. Major Players of Beta Blockers
Table 8. Major Players of Aldosterone Antagonists
Table 9. Major Players of Diuretics
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Table 12. Global Heart Failure Drugs Revenue by Type (2015-2020) ($ million)
Table 13. Global Heart Failure Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Heart Failure Drugs Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Table 17. Global Heart Failure Drugs Value by Application (2015-2020)
Table 18. Global Heart Failure Drugs Value Market Share by Application (2015-2020)
Table 19. Global Heart Failure Drugs Sale Price by Application (2015-2020)
Table 20. Global Heart Failure Drugs Sales by Company (2017-2019) (MT)
Table 21. Global Heart Failure Drugs Sales Market Share by Company (2017-2019)
Table 22. Global Heart Failure Drugs Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Heart Failure Drugs Revenue Market Share by Company (2017-2019)
Table 24. Global Heart Failure Drugs Sale Price by Company (2017-2019)
Table 25. Global Heart Failure Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Heart Failure Drugs Products Offered
Table 27. Heart Failure Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Heart Failure Drugs Consumption by Regions 2015-2020 (MT)
Table 29. Global Heart Failure Drugs Consumption Market Share by Regions 2015-2020
Table 30. Global Heart Failure Drugs Value by Regions 2015-2020 ($ Millions)
Table 31. Global Heart Failure Drugs Value Market Share by Regions 2015-2020
Table 32. Americas Heart Failure Drugs Consumption by Countries (2015-2020) (MT)
Table 33. Americas Heart Failure Drugs Consumption Market Share by Countries (2015-2020)
Table 34. Americas Heart Failure Drugs Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Heart Failure Drugs Value Market Share by Countries (2015-2020)
Table 36. Americas Heart Failure Drugs Consumption by Type (2015-2020) (MT)
Table 37. Americas Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Table 38. Americas Heart Failure Drugs Consumption by Application (2015-2020) (MT)
Table 39. Americas Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Table 40. APAC Heart Failure Drugs Consumption by Countries (2015-2020) (MT)
Table 41. APAC Heart Failure Drugs Consumption Market Share by Countries (2015-2020)
Table 42. APAC Heart Failure Drugs Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Heart Failure Drugs Value Market Share by Regions (2015-2020)
Table 44. APAC Heart Failure Drugs Consumption by Type (2015-2020) (MT)
Table 45. APAC Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Table 46. APAC Heart Failure Drugs Consumption by Application (2015-2020) (MT)
Table 47. APAC Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Table 48. Europe Heart Failure Drugs Consumption by Countries (2015-2020) (MT)
Table 49. Europe Heart Failure Drugs Consumption Market Share by Countries (2015-2020)
Table 50. Europe Heart Failure Drugs Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Heart Failure Drugs Value Market Share by Countries (2015-2020)
Table 52. Europe Heart Failure Drugs Consumption by Type (2015-2020) (MT)
Table 53. Europe Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Table 54. Europe Heart Failure Drugs Consumption by Application (2015-2020) (MT)
Table 55. Europe Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Heart Failure Drugs Consumption by Countries (2015-2020) (MT)
Table 57. Middle East & Africa Heart Failure Drugs Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Heart Failure Drugs Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Heart Failure Drugs Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Heart Failure Drugs Consumption by Type (2015-2020) (MT)
Table 61. Middle East & Africa Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Heart Failure Drugs Consumption by Application (2015-2020) (MT)
Table 63. Middle East & Africa Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Table 64. Heart Failure Drugs Distributors List
Table 65. Heart Failure Drugs Customer List
Table 66. Global Heart Failure Drugs Consumption Forecast by Countries (2021-2025) (MT)
Table 67. Global Heart Failure Drugs Consumption Market Forecast by Regions
Table 68. Global Heart Failure Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Heart Failure Drugs Value Market Share Forecast by Regions
Table 70. Global Heart Failure Drugs Consumption Forecast by Type (2021-2025) (MT)
Table 71. Global Heart Failure Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Heart Failure Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Heart Failure Drugs Value Market Share Forecast by Type (2021-2025)
Table 74. Global Heart Failure Drugs Consumption Forecast by Application (2021-2025) (MT)
Table 75. Global Heart Failure Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Heart Failure Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Heart Failure Drugs Value Market Share Forecast by Application (2021-2025)
Table 78. Novartis Product Offered
Table 79. Novartis Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Novartis Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sun Pharma Product Offered
Table 84. Sun Pharma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 85. Sun Pharma Main Business
Table 86. Sun Pharma Latest Developments
Table 87. Sun Pharma Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Product Offered
Table 89. Pfizer Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Pfizer Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Hikma Product Offered
Table 94. Hikma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 95. Hikma Main Business
Table 96. Hikma Latest Developments
Table 97. Hikma Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Product Offered
Table 99. Teva Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Teva Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Product Offered
Table 104. AstraZeneca Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. AstraZeneca Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Amgen Product Offered
Table 109. Amgen Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Amgen Main Business
Table 111. Amgen Latest Developments
Table 112. Amgen Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 113. Cipla Product Offered
Table 114. Cipla Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. Cipla Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Roche Product Offered
Table 119. Roche Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 120. Roche Main Business
Table 121. Roche Latest Developments
Table 122. Roche Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck & Co. Product Offered
Table 124. Merck & Co. Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 125. Merck & Co. Main Business
Table 126. Merck & Co. Latest Developments
Table 127. Merck & Co. Basic Information, Company Total Revenue (in $ million), Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Mylan Product Offered
Table 129. Mylan Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 130. Mylan Main Business
Table 131. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Mylan Latest Developments
List of Figures
Figure 1. Picture of Heart Failure Drugs
Figure 2. Heart Failure Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Heart Failure Drugs Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Heart Failure Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of ACEI
Figure 7. Product Picture of Angiotensin II Receptor Blockers
Figure 8. Product Picture of ARNIs
Figure 9. Product Picture of Beta Blockers
Figure 10. Product Picture of Aldosterone Antagonists
Figure 11. Product Picture of Diuretics
Figure 12. Global Heart Failure Drugs Consumption Market Share by Type (2015-2020)
Figure 13. Global Heart Failure Drugs Value Market Share by Type (2015-2020)
Figure 14. Heart Failure Drugs Consumed in Reduced Ejection Fraction
Figure 15. Global Heart Failure Drugs Market: Reduced Ejection Fraction (2015-2020) (MT)
Figure 16. Global Heart Failure Drugs Market: Reduced Ejection Fraction (2015-2020) ($ Millions)
Figure 17. Heart Failure Drugs Consumed in Preserved Ejection Fraction
Figure 18. Global Heart Failure Drugs Market: Preserved Ejection Fraction (2015-2020) (MT)
Figure 19. Global Heart Failure Drugs Market: Preserved Ejection Fraction (2015-2020) ($ Millions)
Figure 20. Global Heart Failure Drugs Consumption Market Share by Application (2015-2020)
Figure 21. Global Heart Failure Drugs Value Market Share by Application (2015-2020)
Figure 22. Global Heart Failure Drugs Sales Market Share by Company in 2017
Figure 23. Global Heart Failure Drugs Sales Market Share by Company in 2019
Figure 24. Global Heart Failure Drugs Revenue Market Share by Company in 2017
Figure 25. Global Heart Failure Drugs Revenue Market Share by Company in 2019
Figure 26. Global Heart Failure Drugs Sale Price by Company in 2019
Figure 27. Global Heart Failure Drugs Consumption Market Share by Regions 2015-2020
Figure 28. Global Heart Failure Drugs Value Market Share by Regions 2015-2020
Figure 29. Americas Heart Failure Drugs Consumption 2015-2020 (MT)
Figure 30. Americas Heart Failure Drugs Value 2015-2020 ($ Millions)
Figure 31. APAC Heart Failure Drugs Consumption 2015-2020 (MT)
Figure 32. APAC Heart Failure Drugs Value 2015-2020 ($ Millions)
Figure 33. Europe Heart Failure Drugs Consumption 2015-2020 (MT)
Figure 34. Europe Heart Failure Drugs Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Heart Failure Drugs Consumption 2015-2020 (MT)
Figure 36. Middle East & Africa Heart Failure Drugs Value 2015-2020 ($ Millions)
Figure 37. Americas Heart Failure Drugs Consumption Market Share by Countries in 2019
Figure 38. Americas Heart Failure Drugs Value Market Share by Countries in 2019
Figure 39. Americas Heart Failure Drugs Consumption Market Share by Type in 2019
Figure 40. Americas Heart Failure Drugs Consumption Market Share by Application in 2019
Figure 41. United States Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 42. United States Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 44. Canada Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 46. Mexico Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Heart Failure Drugs Consumption Market Share by Countries in 2019
Figure 48. APAC Heart Failure Drugs Value Market Share by Regions in 2019
Figure 49. APAC Heart Failure Drugs Consumption Market Share by Type in 2019
Figure 50. APAC Heart Failure Drugs Consumption Market Share by Application in 2019
Figure 51. China Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 52. China Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 54. Japan Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 56. Korea Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 58. Southeast Asia Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. India Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 60. India Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 62. Australia Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Heart Failure Drugs Consumption Market Share by Countries in 2019
Figure 64. Europe Heart Failure Drugs Value Market Share by Countries in 2019
Figure 65. Europe Heart Failure Drugs Consumption Market Share by Type in 2019
Figure 66. Europe Heart Failure Drugs Consumption Market Share by Application in 2019
Figure 67. Germany Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 68. Germany Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. France Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 70. France Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 71. UK Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 72. UK Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 74. Italy Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 76. Russia Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Heart Failure Drugs Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Heart Failure Drugs Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Heart Failure Drugs Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Heart Failure Drugs Consumption Market Share by Application in 2019
Figure 81. Egypt Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 82. Egypt Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 84. South Africa Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 86. Israel Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 88. Turkey Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Heart Failure Drugs Consumption Growth 2015-2020 (MT)
Figure 90. GCC Countries Heart Failure Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Global Heart Failure Drugs Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 92. Global Heart Failure Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 94. Americas Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 95. APAC Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 96. APAC Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 97. Europe Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 98. Europe Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 100. Middle East & Africa Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 101. United States Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 102. United States Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 103. Canada Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 104. Canada Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 105. Mexico Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 106. Mexico Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 107. Brazil Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 108. Brazil Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 109. China Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 110. China Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 111. Japan Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 112. Japan Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 113. Korea Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 114. Korea Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 116. Southeast Asia Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 117. India Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 118. India Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 119. Australia Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 120. Australia Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 121. Germany Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 122. Germany Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 123. France Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 124. France Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 125. UK Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 126. UK Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 127. Italy Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 128. Italy Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 129. Russia Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 130. Russia Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 131. Spain Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 132. Spain Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 133. Egypt Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 134. Egypt Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 135. South Africa Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 136. South Africa Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 137. Israel Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 138. Israel Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 139. Turkey Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 140. Turkey Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Heart Failure Drugs Consumption 2021-2025 (MT)
Figure 142. GCC Countries Heart Failure Drugs Value 2021-2025 ($ Millions)
Figure 143. Novartis Heart Failure Drugs Market Share (2018-2020)
Figure 144. Sun Pharma Heart Failure Drugs Market Share (2018-2020)
Figure 145. Pfizer Heart Failure Drugs Market Share (2018-2020)
Figure 146. Hikma Heart Failure Drugs Market Share (2018-2020)
Figure 147. Teva Heart Failure Drugs Market Share (2018-2020)
Figure 148. AstraZeneca Heart Failure Drugs Market Share (2018-2020)
Figure 149. Amgen Heart Failure Drugs Market Share (2018-2020)
Figure 150. Cipla Heart Failure Drugs Market Share (2018-2020)
Figure 151. Roche Heart Failure Drugs Market Share (2018-2020)
Figure 152. Merck & Co. Heart Failure Drugs Market Share (2018-2020)
Figure 153. Mylan Heart Failure Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets